Validation of the GATE Software

N/ACompletedNCT01265628

University Hospital Tuebingen30 enrolled

Overview

Comparison of the differential luminance sensitivity (DLS) values at each test point

Study Type

OBSERVATIONAL

Enrollment

Conditions

Visual Field Defects

Interventions

perimetryPROCEDURE

automated static perimetry with adapted GATE strategy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * physical, intellectual and linguistic abilities, in order to understand the test requirements * spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt * distant visual acuity \> 10/20 * isocoria, pupil diameter \> 3 mm Exclusion Criteria: * pregnancy, nursing * diabetic retinopathy * asthma * HIV+ or AIDS * history of epilepsy or significant psychiatric disease * medications known to effect visual field sensitivity * acute ocular infections (e.g. keratitis, conjunctivitis, uveitis) * severe dry eyes * miotic drugs * amblyopia * squint * nystagmus * albinism * keratoconus * intraocular surgery (except for uncomplicated cataract surgery) performed \< 3 month prior to screening * history or presence of macular disease and / or macular edema * relevant opacities of central refractive media (cornea, lens, vitreous body) * ocular trauma

Locations (1)

Centre for Ophthalmology, Institute for Ophthalmic Research

Tübingen, Germany

Outcomes

Primary Outcomes

Validation of visual field data and comparison of the differential luminance sensitivity (DLS) values at each test point by applying two perimetric software versions.

each participant were examined 2 times at two seperate sessions within 14 days.

Time frame: up to 14 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.